Brain function in classic galactosemia, a galactosemia network (GalNet) members review.

brain classic galactosemia cognitive problems galactose movement disorders neurodevelopment neuropsychiatry

Journal

Frontiers in genetics
ISSN: 1664-8021
Titre abrégé: Front Genet
Pays: Switzerland
ID NLM: 101560621

Informations de publication

Date de publication:
2024
Historique:
received: 14 12 2023
accepted: 24 01 2024
medline: 1 3 2024
pubmed: 1 3 2024
entrez: 1 3 2024
Statut: epublish

Résumé

Classic galactosemia (CG, OMIM #230400, ORPHA: 79,239) is a hereditary disorder of galactose metabolism that, despite treatment with galactose restriction, affects brain function in 85% of the patients. Problems with cognitive function, neuropsychological/social emotional difficulties, neurological symptoms, and abnormalities in neuroimaging and electrophysiological assessments are frequently reported in this group of patients, with an enormous individual variability. In this review, we describe the role of impaired galactose metabolism on brain dysfunction based on state of the art knowledge. Several proposed disease mechanisms are discussed, as well as the time of damage and potential treatment options. Furthermore, we combine data from longitudinal, cross-sectional and retrospective studies with the observations of specialist teams treating this disease to depict the brain disease course over time. Based on current data and insights, the majority of patients do not exhibit cognitive decline. A subset of patients, often with early onset cerebral and cerebellar volume loss, can nevertheless experience neurological worsening. While a large number of patients with CG suffer from anxiety and depression, the increased complaints about memory loss, anxiety and depression at an older age are likely multifactorial in origin.

Identifiants

pubmed: 38425716
doi: 10.3389/fgene.2024.1355962
pii: 1355962
pmc: PMC10902464
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1355962

Informations de copyright

Copyright © 2024 Panis, Vos, Barić, Bosch, Brouwers, Burlina, Cassiman, Coman, Couce, Das, Demirbas, Empain, Gautschi, Grafakou, Grunewald, Kingma, Knerr, Leão-Teles, Möslinger, Murphy, Õunap, Pané, Paci, Parini, Rivera, Scholl-Bürgi, Schwartz, Sdogou, Shakerdi, Skouma, Stepien, Treacy, Waisbren, Berry and Rubio-Gozalbo.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Auteurs

Bianca Panis (B)

Department of Pediatrics, MosaKids Children's Hospital, Maastricht University Medical Centre, Maastricht, Netherlands.
European Reference Network for Hereditary Metabolic Disorders (MetabERN) Member, Padova, Italy.
United for Metabolic Diseases (UMD), Amsterdam, Netherlands.

E Naomi Vos (EN)

Department of Pediatrics, MosaKids Children's Hospital, Maastricht University Medical Centre, Maastricht, Netherlands.
European Reference Network for Hereditary Metabolic Disorders (MetabERN) Member, Padova, Italy.
United for Metabolic Diseases (UMD), Amsterdam, Netherlands.
Department of Clinical Genetics, Maastricht University Medical Centre, Maastricht, Netherlands.
GROW School for Oncology and Reproduction, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, Netherlands.

Ivo Barić (I)

Department of Pediatrics, University Hospital Center Zagreb, Croatia, and School of Medicine, University of Zagreb, Zagreb, Croatia.

Annet M Bosch (AM)

European Reference Network for Hereditary Metabolic Disorders (MetabERN) Member, Padova, Italy.
United for Metabolic Diseases (UMD), Amsterdam, Netherlands.
Department of Pediatrics, Division of Metabolic Diseases, Emma Children's Hospital, Amsterdam University Medical Center, Amsterdam Gastroenterology Endocrinology Metabolism, Inborn Errors of Metabolism, Amsterdam, Netherlands.

Martijn C G J Brouwers (MCGJ)

European Reference Network for Hereditary Metabolic Disorders (MetabERN) Member, Padova, Italy.
Department of Internal Medicine, Division of Endocrinology and Metabolic Disease, Maastricht University Medical Centre, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, Netherlands.

Alberto Burlina (A)

European Reference Network for Hereditary Metabolic Disorders (MetabERN) Member, Padova, Italy.
Division of Inherited Metabolic Diseases, Reference Centre Expanded Newborn Screening, University Hospital Padova, Padova, Italy.

David Cassiman (D)

Laboratory of Hepatology, Department of Chronic Diseases, Metabolism and Ageing, Faculty of Medicine, KU Leuven, Leuven, Belgium.

David J Coman (DJ)

Queensland Children's Hospital, Children's Health Queensland, Brisbane, QLD, Australia.

María L Couce (ML)

European Reference Network for Hereditary Metabolic Disorders (MetabERN) Member, Padova, Italy.
Department of Pediatrics, Diagnosis and Treatment Unit of Congenital Metabolic Diseases, University Clinical Hospital of Santiago de Compostela, IDIS-Health Research Institute of Santiago de Compostela, CIBERER, RICORS Instituto Salud Carlos III, Santiago de Compostela, Spain.

Anibh M Das (AM)

European Reference Network for Hereditary Metabolic Disorders (MetabERN) Member, Padova, Italy.
Department of Paediatrics, Pediatric Metabolic Medicine, Hannover Medical School, Hannover, Germany.

Didem Demirbas (D)

Division of Genetics and Genomics, Boston Children's Hospital, Harvard Medical School, Manton Center for Orphan Disease Research, Boston, MA, United States.

Aurélie Empain (A)

European Reference Network for Hereditary Metabolic Disorders (MetabERN) Member, Padova, Italy.
Department of Paediatrics, Metabolic and Nutrition Unit, Division of Endocrinology, Diabetes and Metabolism, University Hospital for Children Queen Fabiola, Bruxelles, Belgium.

Matthias Gautschi (M)

Department of Paediatrics, Institute of Clinical Chemistry, Inselspital, Bern University Hospital, Swiss Reference Centre for Inborn Errors of Metabolism, Site Bern, Division of Pediatric Endocrinology, Diabetes and Metabolism, University of Bern, Bern, Switzerland.

Olga Grafakou (O)

European Reference Network for Hereditary Metabolic Disorders (MetabERN) Member, Padova, Italy.
IEM Clinic, Arch Makarios III Hospital, Nicosia, Cyprus.

Stephanie Grunewald (S)

Metabolic Unit Great Ormond Street Hospital and Institute for Child Health, University College London, London, United Kingdom.

Sandra D K Kingma (SDK)

European Reference Network for Hereditary Metabolic Disorders (MetabERN) Member, Padova, Italy.
Centre for Metabolic Diseases, University Hospital Antwerp, University of Antwerp, Antwerp, Belgium.

Ina Knerr (I)

National Centre for Inherited Metabolic Disorders, Children's Health Ireland at Temple Street, University College Dublin, Dublin, Ireland.

Elisa Leão-Teles (E)

European Reference Network for Hereditary Metabolic Disorders (MetabERN) Member, Padova, Italy.
Reference Centre of Inherited Metabolic Diseases, Centro Hospitalar Universitário São João, Porto, Portugal.

Dorothea Möslinger (D)

European Reference Network for Hereditary Metabolic Disorders (MetabERN) Member, Padova, Italy.
Department of Paediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.

Elaine Murphy (E)

Charles Dent Metabolic Unit, National Hospital for Neurology and Neurosurgery (NHNN), London, United Kingdom.

Katrin Õunap (K)

European Reference Network for Hereditary Metabolic Disorders (MetabERN) Member, Padova, Italy.
Genetics and Personalized Medicine Clinic, Faculty of Medicine, Tartu University Hospital, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.

Adriana Pané (A)

European Reference Network for Hereditary Metabolic Disorders (MetabERN) Member, Padova, Italy.
Endocrinology and Nutrition Department, Hospital Clínic de Barcelona, Centro de Investigación Biomédica en Red de la Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.

Sabrina Paci (S)

European Reference Network for Hereditary Metabolic Disorders (MetabERN) Member, Padova, Italy.
Inborn Errors of Metabolism, Clinical Department of Pediatrics, San Paolo Hospital - ASST Santi Paolo e Carlo, University of Milan, Milan, Italy.

Rossella Parini (R)

European Reference Network for Hereditary Metabolic Disorders (MetabERN) Member, Padova, Italy.
Rare Diseases Unit, Department of Internal Medicine, San Gerardo Hospital IRCCS, Monza, Italy.

Isabel A Rivera (IA)

iMed.ULisboa-Instituto de Investigação do Medicamento, Faculdade de Farmácia, Universidade de Lisboa, Lisboa, Portugal.

Sabine Scholl-Bürgi (S)

29 Department of Child and Adolescent Health, Division of Pediatrics I-Inherited Metabolic Disorders, Medical University Innsbruck, Innsbruck, Austria.

Ida V D Schwartz (IVD)

Medical Genetics Service, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil.

Triantafyllia Sdogou (T)

European Reference Network for Hereditary Metabolic Disorders (MetabERN) Member, Padova, Italy.
Newborn Screening Department, Institute of Child Health, Athens, Greece.

Loai A Shakerdi (LA)

Adult Metabolics/Genetics, National Centre for Inherited Metabolic Disorders, The Mater Misericordiae University Hospital, Dublin, Ireland.

Anastasia Skouma (A)

European Reference Network for Hereditary Metabolic Disorders (MetabERN) Member, Padova, Italy.
Newborn Screening Department, Institute of Child Health, Athens, Greece.

Karolina M Stepien (KM)

Salford Royal Organisation, Northern Care Alliance NHS Foundation Trust, Salford, United Kingdom.

Eileen P Treacy (EP)

School of Medicine, Trinity College Dublin, National Rare Diseases Office, Mater Misericordiae University Hospital, Dublin, Ireland.

Susan Waisbren (S)

Division of Genetics and Genomics, Boston Children's Hospital, Harvard Medical School, Manton Center for Orphan Disease Research, Boston, MA, United States.

Gerard T Berry (GT)

Division of Genetics and Genomics, Boston Children's Hospital, Harvard Medical School, Manton Center for Orphan Disease Research, Boston, MA, United States.

M Estela Rubio-Gozalbo (ME)

Department of Pediatrics, MosaKids Children's Hospital, Maastricht University Medical Centre, Maastricht, Netherlands.
European Reference Network for Hereditary Metabolic Disorders (MetabERN) Member, Padova, Italy.
United for Metabolic Diseases (UMD), Amsterdam, Netherlands.
Department of Clinical Genetics, Maastricht University Medical Centre, Maastricht, Netherlands.
GROW School for Oncology and Reproduction, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, Netherlands.

Classifications MeSH